Lilly Sues Watson Over Application to Market Generic Evista

Drug Industry Daily
A A
Eli Lilly has filed a patent-infringement suit against Watson Pharmaceuticals after the company submitted an application to market a generic version of Lilly’s postmenopausal osteoporosis drug Evista.

To View This Article:

Login

Subscribe To Drug Industry Daily